Concepedia

Drug Repurposing

Drug repurposing is a pharmaceutical development strategy that identifies and applies new therapeutic indications for existing drugs with established safety and pharmacological profiles beyond their original clinical uses.

1.9K

Publications

103.3K

Citations

9.8K

Authors

2.9K

Institutions

Publications per year

2017–2026

753

Variants

Drug Re-profilingDrug Repositioning

Parents

Children

Publications

1.9K

Rituximab for rheumatoid arthritis refractory to anti–tumor necrosis factor therapy: Results of a multicenter, randomized, double‐blind, placebo‐controlled, phase III trial evaluating primary efficacy and safety at twenty‐four weeks

Stanley Cohen, Paul Emery, Maria Greenwald et al. · Arthritis & Rheumatism · 2006 · 1.6K citations

, , +16

Febuxostat Compared with Allopurinol in Patients with Hyperuricemia and Gout

Michael A. Becker, H. Ralph Schumacher, Robert L. Wortmann et al. · New England Journal of Medicine · 2005 · 1.4K citations · Full text

, , +14

Early Remdesivir to Prevent Progression to Severe Covid-19 in Outpatients

Robert Gottlieb, Carlos Vaca, Roger Paredes et al. · New England Journal of Medicine · 2021 · 1.3K citations · Full text

, , +13

Spironolactone versus placebo, bisoprolol, and doxazosin to determine the optimal treatment for drug-resistant hypertension (PATHWAY-2): a randomised, double-blind, crossover trial

Bryan Williams, Thomas M. MacDonald, S. V. Morant et al. · The Lancet · 2015 · 1.2K citations · Full text

, , +16

Recombinant Tissue-Type Plasminogen Activator (Alteplase) for Ischemic Stroke 3 to 5 Hours After Symptom Onset

Wayne M. Clark, S. Wissman, Gregory W. Albers et al. · JAMA · 1999 · 1.2K citations · Full text

, , +6

1–5 of 1.9K

Authors

9.8K

  1. RT
    Robert Terkeltaub

    University of California San Diego, United States

    9 publications · 676 citations

    10

    h-index

  2. EK
    Edward Keystone

    University of Toronto, Canada

    9 publications · 3.2K citations

    9

    h-index

  3. DV
    Désirée van der Heijde

    Leiden University Medical Center, Netherlands

    9 publications · 1.1K citations

    9

    h-index

  4. PE
    Paul Emery

    University of Leeds, United Kingdom

    9 publications · 3.1K citations

    9

    h-index

  5. PP
    Pan Pantziarka

    Anticancer Fund, Belgium

    8 publications · 412 citations

    8

    h-index

1–5 of 9.8K

Institutions

2.9K

  1. Inserm

    Paris, France

    25 h-index

    108 publications

    8.2K citations

  2. University of California San Diego

    San Diego, United States

    23 h-index

    55 publications

    6.6K citations

  3. Harvard University

    Cambridge, United States

    23 h-index

    84 publications

    8.8K citations

  4. Stanford University

    Stanford, United States

    21 h-index

    68 publications

    8.4K citations

  5. Brigham and Women's Hospital

    Boston, United States

    20 h-index

    56 publications

    5.6K citations

  6. Johns Hopkins University

    Baltimore, United States

    20 h-index

    85 publications

    6.3K citations

  7. Leiden University Medical Center

    Leiden, The Netherlands

    18 h-index

    63 publications

    6K citations

  8. University College London

    London, United Kingdom

    18 h-index

    78 publications

    47.9K citations

1–8 of 2.9K

Venues

  1. PubMed

    Repository · 130 publications · 4.6K citations

    34

    h-index

  2. Annals of the Rheumatic Diseases

    ARD · 38 publications · 2.6K citations

    27

    h-index

  3. The Journal of Urology

    25 publications · 1.5K citations

    20

    h-index

  4. British Journal of Dermatology

    16 publications · 821 citations

    15

    h-index

  5. Frontiers in Pharmacology

    16 publications · 718 citations

    15

    h-index

1–5

See also

Drug Repurposing

Core Methods

Applications

Evaluation

Data Sources

Limitations